World Novartis agrees to $642mn US settlement over kickbacks

07:32  02 july  2020
07:32  02 july  2020 Source:   msn.com

Prison sentence against ex-FIFA Vice Napout confirmed

 Prison sentence against ex-FIFA Vice Napout confirmed On June 22, an appeals court in New York confirmed the criminal convictions of former football officials Juan Ángel Napout (62) and José Maria Marin (88). © Photo: Patrick Seeger / dpa Received a nine-year prison sentence: Former FIFA Vice President Juan Ángel Napout from Paraguay. That leaves the nine-year prison sentence against former FIFA Vice-President Napout from Paraguay. The former head of Brazilian football, José Maria Marin, however, was released in April because of his advanced age.

Novartis AG agreed to pay more than 9 million to settle U . S . government charges it paid illegal kickbacks to doctors and patients to boost drug sales, the U . S . In connection with the settlements , Novartis agreed to curtail its speaker programs and enter a five-year corporate integrity agreement.

Novartis Pharmaceuticals Corp will pay 0 million to settle U . S . charges that it paid specialty pharmacies illegal kickbacks in exchange for inducing patients to refill certain medications, according to an accord announced Friday. Novartis agreed in principle to pay 0 million to settle U . S

a sign in front of a building: Novartis' headquarters in Basel, Switzerland © SEBASTIEN BOZON Novartis' headquarters in Basel, Switzerland

Swiss pharmaceutical giant Novartis has agreed to pay more than $642 million to settle a lawsuit which accused it of paying kickbacks to doctors, among other allegations, the US Department of Justice said Wednesday.

Part of the settlement pertained to the company's use of three foundations to funnel payments to cover costs for patients taking its multiple sclerosis drug Gilenya and kidney cancer drug Afinitor.

Another part centered on alleged bribing of doctors to prescribe the company's medication.

"Through this settlement and others, the government has demonstrated its commitment to ensuring that drug companies do not use kickbacks to influence the drugs prescribed by doctors or purchased by patients," Assistant Attorney General Jody Hunt said.

Bayer pays out $15.9b to settle Roundup cancer claims

  Bayer pays out $15.9b to settle Roundup cancer claims Global pharmaceutical giant Bayer will spend up to $US10.9 billion ($15.87b) to settle thousands of lawsuits alleging the company's weedkiller, Roundup, causes cancer. The Germany-based company, which bought Roundup maker Monsanto two years ago, said the settlement would cover about 95,000 cases.Many of the claims were filed by homeowners and groundskeepers, but the company still faces thousands more claims from people who have not agreed to settle.The overall sum includes $US1.25b ($1.82b) to settle potential future litigation, which the company has proposed would be covered by a class agreement.

Confidential settlement talks between Novartis AG and the U . S . government over Read More: Novartis Must Face U . S . Suit Claiming Prescription Kickbacks . While Berman said the settlement will be "substantially complete" by June 18, the parties have until August 13 to finalize and execute it.

Novartis is set to pay the U . S . government 0 million in settlement over charges that the Swiss drug maker engaged in improper business conduct with specialty pharmacies. The federal suit alleged that Novartis gave kickbacks to certain pharmacies to push its drugs to patients.

Novartis is accused of having hosted tens of thousands of speaker programs and events which the Department of Justice said were used to bribe physicians.

In one example, the company chose doctors who already prescribed high volumes of Novartis drugs to serve as paid speakers, as a means of inducing them to continue writing or write more prescriptions.

Representatives often dropped doctors from the speaker program if they failed to increase prescriptions, the Department of Justice said.

"For more than a decade, Novartis spent hundreds of millions of dollars on so-called speaker programs, including speaking fees, exorbitant meals and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis' drugs,” said acting US Attorney Audrey Strauss for the Southern District of New York.

Bayer to keep selling Roundup in Australia, will fight local lawsuits

  Bayer to keep selling Roundup in Australia, will fight local lawsuits Bayer will keep selling glyphosate-based weedsprays in Australia and fight litigation here against its product Roundup, despite agreeing to settle US claims.Executives from the company's United States and Australian operations vigorously defended glyphosate weedsprays in an early morning media call on Thursday, saying the product was safe to use and backed by a large body of scientific evidence around the world collected over many decades.

US Bioservices, the specialty pharmacy unit of AmerisourceBergen, has agreed to pay .4 million The company did not admit doing anything wrong as part of the settlement , but the lawsuit claimed The government alleges that Novartis invited the same doctors to speaker events over and over

Novartis agrees to pay m following charges it used charities to pay kickbacks to Medicare patients. You can add Novartis (NVS) to the list of drug makers settling allegations that donations made to patient charities amounted to kickbacks paid to Medicare patients as a way to cover their

The Department of Justice said the activity was the result of decisions made by top management at Novartis’ North American headquarters in New Jersey.

Under the settlement, Novartis will participate in a five-year corporate integrity agreement with the Department of Health and Human Services to address company conduct.


Video: Bayer bets on science in bid to prevent future Roundup lawsuits: legal experts (Reuters)

Novartis agrees to pay more than $ 642 million to end lawsuits .
© SEBASTIEN BOZON Novartis has agreed to pay more than $ 642 million to end lawsuits brought by the American justice system which accused the pharmaceutical group in particular swiss for paying large bribes to doctors Novartis has agreed to pay more than $ 642 million to end prosecutions brought by the American justice system which accused the Swiss pharmaceutical group in particular of having paid important bribes to doctors, the US Department of Justice said on Wednesday.

—   Share news in the SOC. Networks
usr: 11
This is interesting!